4 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Top 13%
#703 out of 5550 analysts
Average Return
+2.52%
Win Rate
38%251 out of 660
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +1,388.81% | $1.34 | $19.95 | 2025-04-14 - 2026-04-10 | Buy |
Prelude Therapeutics IncPRLD | +620.13% | $0.61 | $4.40 | 2025-04-08 - 2026-04-07 | Buy |
Cogent Biosciences IncCOGT | +488.51% | $5.31 | $31.25 | 2025-05-20 - 2026-05-19 | Buy |
Relay Therapeutics IncRLAY | +481.07% | $3.54 | $20.57 | 2025-08-26 - 2026-08-25 | Buy |
IMMIX Biopharma IncIMMX | +478.10% | $2.10 | $12.14 | 2025-09-12 - 2026-09-11 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Black Diamond Therapeutics IncBDTX | 17 | Buy | $11.00 | +517.98% | Reiterates | 4 days ago |
Tango Therapeutics IncTNGX | 16 | Buy | $68.00 | +199.30% | Reiterates | 4 days ago |
Tuhura Biosciences IncHURA | 6 | Buy | $10.00 | +418.13% | Reiterates | 6 days ago |
Enliven Therapeutics IncELVN | 8 | Buy | $73.00 | +64.97% | Maintains | 14 days ago |
Nurix Therapeutics IncNRIX | 27 | Buy | $36.00 | +34.33% | Maintains | 18 days ago |
Arrivent Biopharma IncAVBP | 14 | Buy | $27.00 | +81.57% | Maintains | 25 days ago |
Caribou Biosciences IncCRBU | 18 | Hold | N/A | N/A | Downgrades | 25 days ago |
Cullinan Therapeutics IncCGEM | 9 | Buy | $35.00 | +132.87% | Reiterates | a month ago |
Adicet Bio IncACET | 6 | Buy | $34.00 | +894.15% | Maintains | a month ago |
Telix Pharmaceuticals LtdTLX | 10 | Buy | $20.00 | +119.78% | Reiterates | a month ago |
Cogent Biosciences IncCOGT | 18 | Buy | $55.00 | +77.30% | Reiterates | 2 months ago |
Cardiff Oncology IncCRDF | 6 | Buy | $9.00 | +911.24% | Upgrades | 2 months ago |
Pmv Pharmaceuticals IncPMVP | 12 | Buy | $5.00 | +281.68% | Reiterates | 2 months ago |
Blossomhill Therapeutics IncBLSM | 1 | Buy | $35.00 | +154.55% | Initiates Coverage On | 2 months ago |
Revolution Medicines IncRVMD | 24 | Buy | $280.00 | +46.36% | Maintains | 2 months ago |
Zymeworks IncZYME | 27 | Buy | $55.00 | +92.24% | Maintains | 2 months ago |
Inhibrx Biosciences IncINBX | 1 | Buy | $245.00 | +241.32% | Initiates Coverage On | 2 months ago |
Relay Therapeutics IncRLAY | 25 | Buy | $29.00 | +58.04% | Maintains | 2 months ago |
Elicio Therapeutics IncELTX | 12 | Buy | $23.00 | +1,269.05% | Reiterates | 2 months ago |
IMMIX Biopharma IncIMMX | 14 | Buy | $25.00 | +225.52% | Maintains | 3 months ago |
Oric Pharmaceuticals IncORIC | 31 | Buy | $27.00 | +192.21% | Maintains | 3 months ago |
Karyopharm Therapeutics IncKPTI | 7 | Hold | $3.00 | +353.17% | Downgrades | 3 months ago |
Prelude Therapeutics IncPRLD | 19 | Buy | $8.00 | +106.19% | Reiterates | 3 months ago |
Nuvation Bio IncNUVB | 20 | Buy | $21.00 | +341.18% | Maintains | 3 months ago |
Onkure Therapeutics IncOKUR | 6 | Buy | $21.00 | +701.53% | Maintains | 3 months ago |
Exelixis IncEXEL | 17 | Buy | $56.00 | -19.30% | Reiterates | 4 months ago |
Adc Therapeutics SaADCT | 23 | Hold | N/A | N/A | Downgrades | 5 months ago |
Fate Therapeutics IncFATE | 9 | Buy | $7.00 | +236.54% | Reiterates | 5 months ago |
Radiopharm Theranostics LtdRADX | 1 | Buy | $16.00 | +1,381.48% | Initiates Coverage On | 5 months ago |
Aktis Oncology IncAKTS | 3 | Buy | $35.00 | +119.71% | Maintains | 5 months ago |
Bolt Biotherapeutics IncBOLT | 3 | Buy | $7.00 | +6.22% | Reiterates | 5 months ago |
Biontech SeBNTX | 46 | Buy | $130.00 | +47.44% | Reiterates | 6 months ago |
Molecular Partners AgMOLN | 4 | Buy | $13.00 | +263.13% | Reiterates | 6 months ago |
Allogene Therapeutics IncALLO | 16 | Buy | $11.00 | +832.20% | Maintains | 7 months ago |
Replimune Group IncREPL | 20 | Sell | N/A | N/A | Downgrades | 7 months ago |
Bicara Therapeutics IncBCAX | 6 | Buy | $42.00 | +360.02% | Maintains | 7 months ago |
Perspective Therapeutics IncCATX | 7 | Buy | $13.00 | +1,030.43% | Maintains | 7 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 2 | Buy | $29.00 | +1,006.87% | Maintains | 8 months ago |
Macrogenics IncMGNX | 19 | Hold | $2.00 | -16.67% | Reiterates | a year ago |
Repare Therapeutics IncRPTX | 19 | Buy | $3.00 | N/A | Maintains | a year ago |
Y Mabs Therapeutics IncYMAB | 16 | Hold | $8.60 | N/A | Downgrades | a year ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | N/A | Downgrades | 2 years ago |
Cargo Therapeutics IncCRGX | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Atara Biotherapeutics IncATRA | 13 | Hold | N/A | N/A | Reiterates | 2 years ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | 2 years ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | 2 years ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | 3 years ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 3 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 3 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 3 years ago |
Alpha Compute CorpALP | 5 | Buy | $120.00 | N/A | Maintains | 3 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 3 years ago |
Kinnate Biopharma IncKNTE | 7 | Hold | N/A | N/A | Downgrades | 3 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $3,750.00 | N/A | Reiterates | 3 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 4 years ago |
Tcr2 Therapeutics IncTCRR | 5 | Hold | N/A | N/A | Downgrades | 4 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 4 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 5 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 5 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 6 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.